Clinical Trial Update: Pivotal Study in Advanced Parkinsons Disease Patients [Phase 3]

View source ↗

Summary

Boehringer Ingelheim reports completion and posting of results from a pivotal Phase 3 trial in advanced Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-02-08